Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CASP2 | P42575 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22664218 | 0.92 | MEN1 (0.45) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL25876080 | 0.92 | MEN1 (0.45) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL20134457 | 0.92 | CASP2 (0.62) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL25475907 | 0.92 | MEN1 (0.45) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL20417361 | 0.92 | CASP2 (0.62) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL20121986 | 0.92 | CASP2 (0.62) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL23567476 | 0.92 | CASP2 (0.62) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL24193577 | 0.92 | MEN1 (0.45) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL19750382 | 0.90 | MEN1 (0.43) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL22280403 | 0.90 | MEN1 (0.43) | MEN1KMT2AALDH1A1SMN1; SMN2CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179665-A1 | COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF | PARABILIS MEDICINES, INC. | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179665-A1 | COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF | IAPP, VIP, NGLY1 | MEN1 244/4885KMT2A 4529/4885ALDH1A1 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.